New funding awards - January 2016

Sponsored Research

Gillian D. Schmidler of Cardiology has received an award (HHSA290201500004I-TO7) from the Agency for Healthcare Research and Quality for a project entitled "Evidence-based Practice Centers (EPC) V TO 19 Post Myocardial Infraction Depression- TR." Total funding will be $125,000.

Svati H. Shah of Cardiology has received an award (1R01-HL127009-01A1) from the National Institutes of Health for a project entitled "A Personalized Metabolomic Approach to Human Obesity and Weight Loss." Total funding will be $2,057,420.

Albert Y. Sun of Cardiology has received a sub-award (R01-HL116906) through the Cincinnati Children's Hospital Medical Center for a project entitled "ARVC."

Mehri McKellar of Infectious Diseases has received an award from the City of Durham Community Development Department for a project entitled "Housing Opportunities for Persons with AIDs." Total funding will be $140,663.

Steve Taylor of Infectious Diseases has received an award (1R21-AI120981-01) from the National Institutes of Health for a project entitled "Bloodborne tropical pathogen detection using multiple nanophotonic arrays." Total funding will be $411,122.

Michael J. Kelley of Medical Oncology has received an award from the Chordoma Foundation for a project entitled "Chordoma Foundation Brachyury Mouse Model Project." Total funding will be $49,500.

Gretchen G. Kimmick of Medical Oncology has received a sub-award through the University of North Carolina - Chapel Hill for a project entitled "LCCC 1410: Impact of Physical Activity on Biomarker of Aging and Body Composition among Breast Cancer Survivors Age 65 and Older." Total funding will be $28,900.

Neil R. MacIntyre of Pulmonary, Allergy, and Critical Care Medicine has received an award (HHSN268200736186C) from the National Institutes of Health for a project entitled "LOTT Option IV Core." Total funding will be $6,413.

Donghai Wang of Rheumatology and Immunology has received an award from the Arthritis Foundation for a project entitled "Regulation of Inflammation by the Mevalonate Pathway in Mouse Model of RA." Total funding will be $42,540.

Donghai Wang of Rheumatology and Immunology has received an award (7R01-AI110695-02) from the National Institutes of Health for a project entitled "Censoring Inflammation by Protein Geranylgeranylation." Total funding will be $1,675,000.

Industry-sponsored Clinical Trials

Melvin R. Echols of Cardiology has received an award from the Cardiovascular Clinical Science Foundation Corporation for a project entitled "Secret of CHF." Total funding will be $43,740.

Eric L. Eisenstein of Cardiology has received an award through Deloitte Consulting LLP for a project entitled "Million Hearts." Total funding will be $251,833.

Ravi Karra of Cardiology has received an award from MedImmune, Inc. for a project entitled "A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of MEDI6012 in Subjects with Stable Coronary Artery Disease." Total funding will be $70,462.

Emily O'Brien of Cardiology has received an award from Pfizer, Inc. for a project entitled "AFIB Kidney Disease." Total funding will be $281,039.

Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Gilead 337-1746: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies." Total funding will be $90,047.

Thomas L. Ortel of Hematology has received an award from Bayer Healthcare Pharmaceuticals Inc for a project entitled "Field Study to evaluate the activity of a site specific of B-Domain Deleted (BDD) pegylated recombinant FVIII protein (BAY 94-9027)." Total funding will be $4,710.

Susanna Naggie of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "HCV/HIV Co-infection Registry." Total funding will be $831,156.

Amy P. Abernethy of Medical Oncology has received an award through Deloitte Consulting LLP for a project entitled "CMS RMADA IDIQ."

Andrew Armstrong of Medical Oncology has received an award from Janssen Research & Development, LLC for a project entitled "Defining the Relevant Immune Checkpoints Expressed on Metastatic Prostate Cancer Circulating Tumor Cells." Total funding will be $402,956.

Jeffrey Crawford of Medical Oncology has received an award from Celgene Corporation for a project entitled "CELGENE SOLID TUMOR PRACTICUM." Total funding will be $78,280.

Herbert I. Hurwitz of Medical Oncology has received an award from Regeneron Pharmaceuticals, Inc. for a project entitled "A first in human study of repeat dosing with REGN2810 a fully human antibody to programmed death - 1 (PD-1) as single therapy and in combination with selected." Total funding will be $339,651.

Megan A. McNamara (Mentor: Daniel J. George) of Medical Oncology has received an award from Bayer Healthcare Pharmaceuticals Inc for a project entitled "Bayer-Exini Radium-223 Retrospective Study." Total funding will be $90,218.

Andrew B. Nixon of Medical Oncology has received an award from Tracon Pharmaceuticals, Inc. for a project entitled "Anti-endoglin mediated modulation of intratumoral Immune Cell Subpopulationg in vivo and effect of combination treatment with anti-PD1 monoclonal antibodies." Total funding will be $70,497.

Neal E. Ready of Medical Oncology has received an award from the Bristol-Myers Squibb Company for a project entitled "An Open-Label, Single Arm Phase II Study of Nivolumab in Combination with Ipilimumab as first line-therapy in stage IV Non-Small Cell Lung Cancer (NSCLC)." Total funding will be $319,305.

Neal E. Ready of Medical Oncology has received an award from the Bristol-Myers Squibb Company for a project entitled "An Open-Label,Randomized Phase 3 trial of Nivolumab, or Nivolumab plus Ipilimumab, versus platinum doublet chemotherapy in Subjects with Chemotherapy-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)." Total funding will be $277,258.

Linda M. Sutton of Medical Oncology has received an award from Genentech, Inc. for a project entitled "A Quality Improvement Approach to the Management of CLL Research." Total funding will be $300,000.

Uptal Patel of Nephrology has received an award through Deloitte Consulting LLP for a project entitled "ACO Model and Comprehensive ESRD Care Initiative." Total funding will be $104,431.

Uptal Patel of Nephrology has received an award from GlaxoSmithKline for a project entitled "A Phase 3 randomized, open-label, active-controlled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety." Total funding will be $650,359.

Uptal Patel of Nephrology has received an award from GlaxoSmithKline for a project entitled "A Phase 3 randomized, open-label, active-controlled, parallel-group, multi-center, event driven study in dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and." Total funding will be $1,122,849.

Shelby Reed of Other Medicine has received an award from Janssen Research & Development, LLC for a project entitled "Janssen TIDM Diabetes Study." Total funding will be $200,924.

Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from Sanofi US for a project entitled "SANOFI EFC-13579 (SAR231893)." Total funding will be $163,322.

Share